Literature DB >> 16115014

Differentiated Alzheimer's disease transmitochondrial cybrid cell lines exhibit reduced organelle movement.

Patricia A Trimmer1, M Kathleen Borland.   

Abstract

The axonal transport and function of organelles like mitochondria and lysosomes may be impaired and play an important role in the pathogenesis of Alzheimer's disease (AD). Unique cybrid cell lines that model AD pathology were created by fusing platelets containing mitochondria from age-matched AD and control volunteers with mitochondrial DNA-free SH-SY5Y human neuroblastoma cells. These cybrid lines were differentiated to form process-bearing neuronal cells. Mitochondria and lysosomes in the neurites of each cybrid line were fluorescently labeled to determine the kinetics of organelle movement. The mitochondria in AD cybrid neurites were elongate, whereas the mitochondria in control cybrid neurites were short and more punctate. The mean velocity of mitochondrial movement, as well as the percentage of moving mitochondria, was significantly reduced in AD cybrids. The velocity of lysosomal movement was also reduced in the processes of AD cybrid cells, suggesting that the axonal transport machinery may be compromised in cybrid cell lines that contain mitochondrial DNA derived from AD patients. Reduced mitochondrial and lysosomal movement in susceptible neurons may compromise function in metabolically demanding structures like synaptic terminals and participate in the terminal degeneration that is characteristic of AD.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16115014     DOI: 10.1089/ars.2005.7.1101

Source DB:  PubMed          Journal:  Antioxid Redox Signal        ISSN: 1523-0864            Impact factor:   8.401


  28 in total

Review 1.  Role of mitochondrial homeostasis and dynamics in Alzheimer's disease.

Authors:  J Eva Selfridge; Lezi E; Jianghua Lu; Russell H Swerdlow
Journal:  Neurobiol Dis       Date:  2012-01-10       Impact factor: 5.996

2.  Mitochondrial gene therapy augments mitochondrial physiology in a Parkinson's disease cell model.

Authors:  Paula M Keeney; Caitlin K Quigley; Lisa D Dunham; Christina M Papageorge; Shilpa Iyer; Ravindar R Thomas; Kathleen M Schwarz; Patricia A Trimmer; Shaharyar M Khan; Francisco R Portell; Kristen E Bergquist; James P Bennett
Journal:  Hum Gene Ther       Date:  2009-08       Impact factor: 5.695

3.  Mitochondrial Dysfunction Triggers Synaptic Deficits via Activation of p38 MAP Kinase Signaling in Differentiated Alzheimer's Disease Trans-Mitochondrial Cybrid Cells.

Authors:  Qing Yu; Fang Du; Justin T Douglas; Haiyang Yu; Shirley ShiDu Yan; Shi Fang Yan
Journal:  J Alzheimers Dis       Date:  2017       Impact factor: 4.472

Review 4.  A mitochondrial etiology of Alzheimer and Parkinson disease.

Authors:  Pinar Coskun; Joanne Wyrembak; Samual E Schriner; Hsiao-Wen Chen; Christine Marciniack; Frank Laferla; Douglas C Wallace
Journal:  Biochim Biophys Acta       Date:  2011-08-16

5.  Systemic mitochondrial dysfunction and the etiology of Alzheimer's disease and down syndrome dementia.

Authors:  Pinar E Coskun; Joanne Wyrembak; Olga Derbereva; Goar Melkonian; Eric Doran; Ira T Lott; Elizabeth Head; Carl W Cotman; Douglas C Wallace
Journal:  J Alzheimers Dis       Date:  2010       Impact factor: 4.472

6.  Antioxidants Rescue Mitochondrial Transport in Differentiated Alzheimer's Disease Trans-Mitochondrial Cybrid Cells.

Authors:  Qing Yu; Du Fang; Russell Howard Swerdlow; Haiyang Yu; John Xi Chen; Shirley ShiDu Yan
Journal:  J Alzheimers Dis       Date:  2016-09-06       Impact factor: 4.472

Review 7.  Mitochondrial abnormalities in Alzheimer's disease: possible targets for therapeutic intervention.

Authors:  Diana F Silva; J Eva Selfridge; Jianghua Lu; Lezi E; Sandra M Cardoso; Russell H Swerdlow
Journal:  Adv Pharmacol       Date:  2012

8.  HDAC6 regulates mitochondrial transport in hippocampal neurons.

Authors:  Sigeng Chen; Geoffrey C Owens; Helen Makarenkova; David B Edelman
Journal:  PLoS One       Date:  2010-05-26       Impact factor: 3.240

Review 9.  Apolipoprotein E: structure and function in lipid metabolism, neurobiology, and Alzheimer's diseases.

Authors:  Yadong Huang; Robert W Mahley
Journal:  Neurobiol Dis       Date:  2014-08-27       Impact factor: 5.996

10.  Reduced axonal transport in Parkinson's disease cybrid neurites is restored by light therapy.

Authors:  Patricia A Trimmer; Kathleen M Schwartz; M Kathleen Borland; Luis De Taboada; Jackson Streeter; Uri Oron
Journal:  Mol Neurodegener       Date:  2009-06-17       Impact factor: 14.195

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.